DIN 02277921 — IGIVNEX 10 G
IGIVNEX is a solution of Immunoglobulin (Human) marketed by GRIFOLS THERAPEUTICS LLC. The full Immunoglobulin (Human) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02277921
- Brand name
- IGIVNEX
- Active ingredient
- Immunoglobulin (Human)
- Strength
- 10 G
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Manufacturer
- GRIFOLS THERAPEUTICS LLC
- Health Canada status
- MARKETED
- Drug class
- Immune globulin (polyvalent human IgG) - passive immunizing and replacement therapy agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Immunoglobulin (Human) products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02461692 | CUVITRU | 200 MG | SOLUTION | TAKEDA CANADA INC | MARKETED |
| 02486598 | GAMASTAN | 18 % | SOLUTION | GRIFOLS THERAPEUTICS LLC | MARKETED |
| 02279444 | GAMMAGARD LIQUID | 10 % | SOLUTION | TAKEDA CANADA INC | MARKETED |
| 02231471 | GAMMAGARD S/D | 10 G | KIT; POWDER FOR SOLUTION; SOLUTION | TAKEDA CANADA INC | DORMANT |
| 02231470 | GAMMAGARD S/D | 5 G | KIT; POWDER FOR SOLUTION; SOLUTION | TAKEDA CANADA INC | MARKETED |
| 02247724 | GAMUNEX | 10 G | SOLUTION | GRIFOLS THERAPEUTICS LLC | MARKETED |
| 02370352 | HIZENTRA | 200 MG | SOLUTION | CSL BEHRING CANADA INC | DORMANT |
| 02463059 | HIZENTRA | 200 MG | SOLUTION | CSL BEHRING CANADA INC | MARKETED |
| 02463067 | HIZENTRA | 200 MG | SOLUTION | CSL BEHRING CANADA INC | MARKETED |
| 02498251 | HIZENTRA | 200 MG | SOLUTION | CSL BEHRING CANADA INC | MARKETED |
| 02535424 | HIZENTRA | 200 MG | SOLUTION | CSL BEHRING CANADA INC | MARKETED |
| 02380145 | OCTAGAM | 100 MG | SOLUTION | OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | DORMANT |
| 02456087 | PANZYGA | 100 MG | SOLUTION | OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | DORMANT |
| 02304619 | PRIVIGEN | 10 % | SOLUTION | CSL BEHRING CANADA INC | MARKETED |